Search

Search Results

• Treatment of spondyloarthritis with disease-modifying anti-rheumatic drugs during pregnancy and breastfeeding: comparing the recommendations and guidelines of the principal societies of rheumatology

  M. Manara, D. Bruno, M. Ferrito, S. Perniola, R.F. Caporali, E. Gremese

  11-09-2024

  https://doi.org/10.4081/reumatismo.2024.1781

  2014

  PDF: 951
• 

  Real-world clinical experience with secukinumab in psoriatic arthritis: an observational study and a literature review

  Eleonora Celletti, Giulio Gualdi, Emanuela Sabatini, Francesco Cipollone, Fabio Lobefaro, Paolo Amerio

  27-01-2025

  https://doi.org/10.4081/reumatismo.2025.1694

  2228

  PDF: 250

• PO:01:007 | Modulation of cellular senescence in psoriatic arthritis: exploring the potential impact of b/tsDMARDs treatment on telomere length, mtDNA copy number, and oxidative damage Eneida Cela¹, Giada De Benedittis², Arianna D'Antonio¹, Andrea Latini³, Chiara Morgante², Cinzia Cicacci³, Paola Conigliaro¹, Mauro Fatica¹, Giulia Mori¹, Giuseppe Novelli², Paola Borgiani², Maria Sole Chimenti¹. | ¹Rheumatology, Allergology and Clinical Immunology, Department of System Medicine, University of Rome Tor Vergata, Rome, Italy; ²Department of Biomedicine and Prevention, Section of Genetics, University of Rome Tor Vergata, Rome, Italy; ³UniCamillus Saint Camillus International University of Health Sciences, Rome, Italy.

  Società Italiana di Reumatologia

  26-11-2025

  https://doi.org/10.4081/reumatismo.2025.2004

  83

• CO:02:4 | Whole blood hypercoagulable profiles in patients with rheumatoid arthritis Lorenzo Di Luozzo¹, Alessandro Giollo¹, Mariangela Salvato¹, Francesca Frizzera¹, Kiren Khalid¹, Luca Spiezia², Andrea Benetti², Chiara Samà², Paolo Simioni², Andrea Doria¹. | ^1Unità di Reumatologia, Azienda Ospedaliera di Padova; ²Dipartimento di Medicina, Università di Padova, Italy

  Società Italiana di Reumatologia

  26-11-2025

  https://doi.org/10.4081/reumatismo.2025.1967

  105

• CO:02:1 | Frequency and predictors of disease progression in contemporary seronegative undifferentiated arthritis in a treated-to-target early arthritis clinic Elena Manna¹, Ludovico De Stefano^1|2, Domenico Sorace^1|2, Jacopo Pelizza^1|2, Blerina Xoxi^1|2, Antonio Manzo^1|2, Carlomaurizio Montecucco^1|2, Serena Bugatti^1|2. | ¹Department of Internal Medicine and Therapeutics, University of Pavia; ²Division of Rheumatology, IRCCS Policlinico San Matteo Foundation, Pavia, Italy

  Società Italiana di Reumatologia

  26-11-2025

  https://doi.org/10.4081/reumatismo.2025.1965

  97

• PO:07:111 | Worsening of patient-reported outcomes is an early predictor of disease flare in patients with rheumatoid arthritis in course of treatment with conventional synthetic disease modifying anti-rheumatic drugs Ludovico De Stefano^1|2, Federica Sabatelli^1|2, Clelia Zampaglione^1|2, Blerina Xoxi², Antonio Manzo^1|2, Carlomaurizio Montecucco^1|2, Serena Bugatti^1|2. | ¹Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy; ²Division of Rheumatology, IRCCS Policlinico San Matteo Foundation, Pavia, Italy.

  Società Italiana di Reumatologia

  26-11-2025

  https://doi.org/10.4081/reumatismo.2025.2022

  60